CollPlant Biotechnologies (CLGN) Gross Profit (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Gross Profit of -$243000.0 for Q1 2026, down 84.09% on a QoQ basis from -$132000.0 in Q4 2025, and down 113.02% year-over-year from $1.9 million in Q1 2025.
CollPlant Biotechnologies (CLGN) Gross Profit (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies' Gross Profit history runs 10 years deep, the most recent figure standing at -$243000.0 for Q1 2026.
- Quarterly Gross Profit fell 113.02% year-over-year to -$243000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$7.0 billion (down 581542.44% YoY) and the FY2025 annual result came in at $1.5 million, up 238.38% from the prior year.
- Gross Profit was -$243000.0 for Q1 2026 at CollPlant Biotechnologies, down from -$132000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $9.6 million in Q2 2023 and bottomed at -$7.0 billion in Q2 2025.
- A 5-year average of -$411.2 million and a median of -$155000.0 in 2022 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2023 — Gross Profit soared 41504.35% — and 2025, when it slumped 2438924.39%.
- CollPlant Biotechnologies' Gross Profit stood at -$4000.0 in 2022, then plunged by 11750.0% to -$474000.0 in 2023, then surged by 77.22% to -$108000.0 in 2024, then dropped by 22.22% to -$132000.0 in 2025, then sank by 84.09% to -$243000.0 in 2026.
- Business Quant data shows CLGN's Gross Profit at -$243000.0 in Q1 2026, -$132000.0 in Q4 2025, and -$192000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -243,000.00 |
| Mar 30, 2026 | -243,000.00 |
| Dec 31, 2025 | -132,000.00 |
| Dec 31, 2025 | -132,000.00 |
| Sep 30, 2025 | -192,000.00 |
| Sep 30, 2025 | -192,000.00 |
| Jun 30, 2025 | -7.00 Bn |
| Jun 30, 2025 | -7.00 Bn |
| Mar 30, 2025 | 1.87 Mn |
| Mar 30, 2025 | 1.87 Mn |
| Dec 31, 2024 | -108,000.00 |
| Dec 31, 2024 | -108,000.00 |
| Sep 30, 2024 | -268,000.00 |
| Sep 30, 2024 | -268,000.00 |
| Jun 30, 2024 | -287,000.00 |
| Jun 30, 2024 | -287,000.00 |
| Mar 31, 2024 | -447,000.00 |
| Mar 31, 2024 | -447,000.00 |
| Dec 31, 2023 | -474,000.00 |
| Dec 31, 2023 | -474,000.00 |